Table of Content


Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 U.S. dialysis industry 360 degree synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Product & service trends
2.1.4 End-use trends
2.1.5 Zonal trends
Chapter 3 US Dialysis Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
3.2.1.2 Increasing incidence of diabetes
3.2.1.3 Shortage of donor kidneys
3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
3.2.1.5 R&D investments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Product recalls
3.2.2.2 Complications in the treatment
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By product & services
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.6 Reimbursement scenario
3.7 Value chain analysis
3.8 Future market trends
3.9 Technology landscape
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Strategy dashboard, 2022
Chapter 5 US Dialysis Market, By Type
5.1 Key type trends
5.2 Hemodialysis
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Peritoneal Dialysis
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 US Dialysis Market, By Product and Services
6.1 Key product and services trends
6.2 Equipment
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Dialysis machines
6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.3 Water treatment systems
6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.4 Others
6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Consumables
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Dialyzers
6.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.3 Catheters
6.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.4 Access products
6.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.5 Concentrates
6.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.6 Others
6.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Services
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.2 Acute dialysis
6.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.3 Chronic dialysis
6.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 US Dialysis Market, By End-use
7.1 Key end-use trends
7.2 In-center dialysis
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Home dialysis
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 US Dialysis Market, By Zone
8.1 Key zonal trends
8.2 East North Central
8.2.1 Illinois
8.2.2 Indiana
8.2.3 Michigan
8.2.4 Ohio
8.2.5 Wisconsin
8.3 West South Central
8.3.1 Arkansas
8.3.2 Louisiana
8.3.3 Oklahoma
8.3.4 Texas
8.4 South Atlantic
8.4.1 Delaware
8.4.2 Florida
8.4.3 Georgia
8.4.4 Maryland
8.4.5 North Carolina
8.4.6 South Carolina
8.4.7 Virginia
8.4.8 West Virginia
8.4.9 Washington, D.C.
8.5 North East
8.5.1 Connecticut
8.5.2 Maine
8.5.3 Massachusetts
8.5.4 New Hampshire
8.5.5 Rhode Island
8.5.6 Vermont
8.5.7 New Jersey
8.5.8 New York
8.5.9 Pennsylvania
8.6 East South Central
8.6.1 Alabama
8.6.2 Kentucky
8.6.3 Mississippi
8.6.4 Tennessee
8.7 West North Central
8.7.1 Iowa
8.7.2 Kansas
8.7.3 Minnesota
8.7.4 Missouri
8.7.5 Nebraska
8.7.6 North Dakota
8.7.7 South Dakota
8.8 Pacific Central
8.8.1 Alaska
8.8.2 California
8.8.3 Hawaii
8.8.4 Oregon
8.8.5 Washington
8.9 Mountain States
8.9.1 Arizona
8.9.2 Colorado
8.9.3 Utah
8.9.4 Nevada
8.9.5 New Mexico
8.9.6 Idaho
8.9.7 Montana
8.9.8 Wyoming
Chapter 9 Company Profiles
9.1 Asahi Kasei Corporation
9.2 American Renal Associates
9.3 B. Braun Melsungen AG
9.4 Baxter International Inc.
9.5 DaVita Inc.
9.6 Becton, Dickinson and Company
9.7 Fresenius Medical Care AG & Co.
9.8 Medtronic plc
9.9 Nipro Corporation
9.10 Sanderling Renal Services
9.11 Toray Industries Inc.
9.12 U.S. Renal Care, Inc.